Qube Research & Technologies LTD Grifols Sa Transaction History

Qube Research & Technologies LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $142,712 - $213,975	18,510 New	18,510 $213,000
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $3.05 Million - $7.34 Million	512,996 New	512,996 $3.16 Million
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $1.05 Million - $1.32 Million	-99,485 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$10.37 - $12.73 $1.46 Million - $1.8 Million	-141,227 Reduced 58.67%	99,485 $1.16 Million
Q4 2021 Feb 01, 2022	BUY	$10.21 - $15.27 $2.34 Million - $3.5 Million	228,963 Added 1948.79%	240,712 $2.7 Million
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $165,308 - $203,257	11,749 New	11,749 $172,000
Q1 2021 May 14, 2021	SELL	$15.15 - $19.78 $995,900 - $1.3 Million	-65,736 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $442,844 - $516,652	26,266 Added 66.55%	65,736 $1.21 Million
Q3 2020 Nov 12, 2020	SELL	$15.4 - $20.16 $4.78 Million - $6.26 Million	-310,593 Reduced 88.72%	39,470 $685,000
Q2 2020 Aug 14, 2020	BUY	$18.24 - $21.45 $5.98 Million - $7.03 Million	327,928 Added 1481.49%	350,063 $6.39 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $1.21 Million - $1.9 Million	-74,214 Reduced 77.03%	22,135 $446,000
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $1.89 Million - $2.27 Million	96,349 New	96,349 $2.24 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.